Synthetic cannabinoid AB-FUBINACA damaged memory and hippocampal cells in mice
Chronic administration of the synthetic cannabinoid AB-FUBINACA impaired recognition memory in mice and caused hippocampal damage through oxidative stress, neuroinflammation, and reduced BDNF expression.
Quick Facts
What This Study Found
AB-FUBINACA caused significant recognition memory impairment along with hippocampal histopathological changes. These effects correlated with increased oxidative stress, neuroinflammation, apoptosis markers, reduced brain-derived neurotrophic factor (BDNF), and decreased NR1 subunit expression of NMDA receptors.
Key Numbers
Significant decreases in BDNF expression and NR1 (NMDA receptor subunit). Increased markers of oxidative stress, neuroinflammation, and apoptosis in hippocampal tissue.
How They Did This
Mouse study evaluating chronic AB-FUBINACA administration effects on hippocampus through behavioral testing (recognition memory), histopathology, and molecular markers of oxidative stress, inflammation, apoptosis, BDNF, and NMDA receptor expression.
Why This Research Matters
Synthetic cannabinoids are far more potent than natural cannabis and are linked to psychiatric emergencies, but the molecular mechanisms behind their neurotoxicity are poorly understood. This study maps specific pathways of hippocampal damage.
The Bigger Picture
The reduced NR1 expression is particularly noteworthy because NMDA receptor dysfunction is implicated in toxic psychosis, a known risk of synthetic cannabinoid use. This provides a molecular link between synthetic cannabinoid exposure and the psychotic episodes reported in users.
What This Study Doesn't Tell Us
Mouse model may not fully translate to human neurotoxicity. Specific doses and administration routes may not match human use patterns. Only studied one synthetic cannabinoid (AB-FUBINACA) out of hundreds.
Questions This Raises
- ?Are these hippocampal changes reversible after cessation?
- ?Do different synthetic cannabinoids produce similar molecular damage patterns?
- ?What doses in humans would correspond to the neurotoxic levels in mice?
Trust & Context
- Key Stat:
- Reduced BDNF and NMDA receptor expression
- Evidence Grade:
- Animal study with detailed molecular analysis, but findings may not directly translate to human neurotoxicity.
- Study Age:
- 2024 mouse study examining AB-FUBINACA neurotoxicity
- Original Title:
- Delineating the molecular mechanisms of hippocampal neurotoxicity induced by chronic administration of synthetic cannabinoid AB-FUBINACA in mice.
- Published In:
- Neurotoxicology, 103, 50-59 (2024)
- Authors:
- Alzu'bi, Ayman(4), Abu-El-Rub, Ejlal(3), Almahasneh, Fatimah(2), Tahat, Lena, Athamneh, Rabaa Y, Khasawneh, Ramada, Alzoubi, Hiba, Ghorab, Doaa S, Almazari, Rawan, Zoubi, Mazhar Salim Al, Al-Zoubi, Raed M
- Database ID:
- RTHC-05077
Evidence Hierarchy
Frequently Asked Questions
What is AB-FUBINACA?
AB-FUBINACA is a synthetic cannabinoid, a lab-made chemical designed to bind to the same brain receptors as THC but often with much greater potency. It has been found in products sold as "spice" or "K2."
How does this differ from natural cannabis effects on the brain?
Synthetic cannabinoids are typically far more potent CB1 receptor agonists than THC. This study found molecular damage (oxidative stress, apoptosis, NMDA disruption) more severe than typically seen with natural cannabis in animal studies.
Read More on RethinkTHC
- THC-purity-potency-label-meaning
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- how-cannabis-products-made-concentrates-edibles
- laced-weed-fentanyl-contaminated-vape
- legal-weed-vs-street-weed-quality-safety
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-05077APA
Alzu'bi, Ayman; Abu-El-Rub, Ejlal; Almahasneh, Fatimah; Tahat, Lena; Athamneh, Rabaa Y; Khasawneh, Ramada; Alzoubi, Hiba; Ghorab, Doaa S; Almazari, Rawan; Zoubi, Mazhar Salim Al; Al-Zoubi, Raed M. (2024). Delineating the molecular mechanisms of hippocampal neurotoxicity induced by chronic administration of synthetic cannabinoid AB-FUBINACA in mice.. Neurotoxicology, 103, 50-59. https://doi.org/10.1016/j.neuro.2024.05.009
MLA
Alzu'bi, Ayman, et al. "Delineating the molecular mechanisms of hippocampal neurotoxicity induced by chronic administration of synthetic cannabinoid AB-FUBINACA in mice.." Neurotoxicology, 2024. https://doi.org/10.1016/j.neuro.2024.05.009
RethinkTHC
RethinkTHC Research Database. "Delineating the molecular mechanisms of hippocampal neurotox..." RTHC-05077. Retrieved from https://rethinkthc.com/research/alzu-bi-2024-delineating-the-molecular-mechanisms
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.